Structure via PubChem · Public domain (PubChem)
Encainide
Sign in to saveAlso known as (+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide, 4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide, 4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide, (+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide, Encainida, Encainidum, (±)-4-methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide
farmaco
Chemical data
- Formula
- C22H28N2O2
- Molecular weight
- 352.5 g/mol
- IUPAC name
- 4-methoxy-N-[2-[2-(1-methylpiperidin-2-yl)ethyl]phenyl]benzamide
- SMILES
- CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC
- InChIKey
- PJWPNDMDCLXCOM-UHFFFAOYSA-N
- XLogP
- 4.3
- Polar surface area
- 41.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
Withdrawn- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1986
- Indications
- cardiac arrhythmia
via ChEMBL · EBI
Research
454 papers- Encainide.Cardiovascular drugs and therapy · 1989
- Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.The New England journal of medicine · 1991
- Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.The New England journal of medicine · 1989
- [Encainide].Medicina (Florence, Italy) · 1988
- Encainide--an updated safety profile.Cardiovascular drugs and therapy · 1990
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 352.215078
- Has use
- medication
Show 6 more facts
- chemical formula
- C₂₂H₂₈N₂O₂
- medical condition treated
- heart arrhythmia
- World Health Organisation international non-proprietary name
- encainide
- canonical SMILES
- CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC
- defined daily dose
- 0.1
- Commons category
- Encainide
Sources (3)
via Wikidata · CC0
Article · Italiano
L'encainide è uno dei farmaci antiaritmici del gruppo IC, che aveva trovato impiego nella terapia delle aritmie ventricolari e sopraventricolari, in particolare nella Sindrome di Wolff-Parkinson-White.
Abstract from DBpedia / Wikipedia · CC BY-SA
Available in 8 languages
via Wikidata sitelinks · CC0